NEO—As we’ve discussed on this board many times, getting paid promptly (or at all) is always an issue for diagnostics companies. True, but this is a potentially onerous problem for NEO in the short-term. If the Barron's author is correct and the FL medicare contractor has completely quit paying, it will hit NEO's cash flow hard as they have their biggest footprint in that state. It is now more clear why they generated some cash with an offer earlier in the year.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.